The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
Surgalign Holdings (NASDAQ: SRGA ) stock is on the rise Tuesday after the company recently received a delisting notice alongside its bankruptcy filing. That delisting notice will result in the compan...
Surgalign Holdings (NASDAQ: SRGA ) stock is taking a beating on Monday after the company revealed a delisting notice from the Nasdaq Exchange. This delisting notice has to do with the company's recen...
Surgalign (NASDAQ: SRGA ) stock is taking a beating on Tuesday after the spine solutions company filed for Chapter 11 bankruptcy. As a result of this filing and plans to cut costs, several changes are...
Surgalign (SRGA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....
Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants David Lyle - Chief Financial Officer Terry Rich - President and Chief Executive Of...
Surgalign Holdings (SRGA) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $3.95. This compares to loss of $2.10 per share a year ago....
DEERFIELD, Ill., May 04, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of dig...
Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants David Lyle - Chief Financial Officer Terry Rich - President and Chief Executive ...
DEERFIELD, Ill., March 21, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of d...